Cumberland Pharmaceuticals (CPIX) Reports Q2 Loss of $0.05
Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of ($0.05), versus $0.00 reported last year. Revenue for the quarter came in at $8.67 thousand, versus $0 reported last year.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
